-
Cyanin Chloride in a HaCaT Psoriasis Model
2026-08-13
A 2024 study tested cyanin chloride in antioxidant, macrophage inflammation, and cytokine-stimulated HaCaT keratinocyte models. Its main innovation was linking reduced psoriasis-associated inflammatory signaling, including STAT3 phosphorylation and CCL20 expression, with functional recovery of epithelial barrier properties measured by TEER.
-
MCC950 sodium: Practical NLRP3 Workflows
2026-08-13
MCC950 sodium enables selective testing of NLRP3-driven cytokine release and pyroptosis across endothelial, macrophage, and disease-model workflows. This guide translates an H2O2-induced endothelial injury study into practical assay design, controls, and troubleshooting strategies.
-
HyperScribe Kit Plus: From mRNA to Nanovaccine
2026-08-12
The HyperScribe Co-transcription mRNA Synthesis Kit Plus connects ARCA-capped, polyadenylated transcript design with demanding translational and mRNA vaccine workflows. This article uses a GPC3-HSP70 nanovaccine study to explain how cap orientation, template architecture, and assay controls influence biological interpretation.
-
Heparin sodium in Translational Assays
2026-08-12
Heparin sodium supports reproducible coagulation studies while offering a practical competition tool for investigating heparan sulfate proteoglycan-dependent nanovesicle uptake. This article connects anti-factor Xa and aPTT workflows with the Cistanche deserticola nanovesicle findings, emphasizing controls, assay selection, and troubleshooting rather than therapeutic extrapolation.
-
PAD4-IN-2 TFA: Tumor-Targeted NET Workflows
2026-08-11
PAD4-IN-2 TFA, also called Compound 5i TFA, connects tumor-biased uptake with functional suppression of the PAD4–H3cit–NET axis. This guide translates the evidence into localization-aware, migration, immune-microenvironment, and troubleshooting workflows for cancer research.
-
PPACK Dihydrochloride in Thrombin Assays
2026-08-10
PPACK Dihydrochloride provides a precise way to suppress thrombin activity while platelet researchers resolve parallel purinergic pathways. This article presents practical assay workflows, control strategies, and troubleshooting guidance for blood coagulation research and platelet aggregation inhibition.
-
Palomid 529 (P529) in PI3K/mTOR Research
2026-08-09
Palomid 529 (P529) is a dual mTORC1/mTORC2 inhibitor for mechanistic cancer research. Product-reported activity in tumor-cell and endothelial assays supports studies of PI3K/Akt/mTOR signaling, tumor angiogenesis inhibition, and radiotherapy enhancement, while ESCC-specific evidence remains a research rationale rather than direct validation.
-
BMAL1, AP-1, and Senescence Programming
2026-08-08
Jachim et al. identify BMAL1 as an active regulator of senescence biology rather than only a circadian clock component. By combining BMAL1 ChIP-seq, RNA-seq, and functional analyses, the study links altered BMAL1 activity to AP-1-associated transcription, survival pathways, and resistance to drug-induced apoptosis.
-
HNF4A-AS1 and Sorafenib Resistance in HCC
2026-08-07
This 2024 Theranostics study identifies liver-enriched lncRNA HNF4A-AS1 as a regulator of sorafenib-induced ferroptosis in hepatocellular carcinoma. Its loss increases DECR1 through an m6A-dependent RNA-stability mechanism, reduces intracellular PUFA availability, and enables drug resistance, providing a mechanistic link between noncoding RNA regulation and lipid metabolic reprogramming.
-
ARCA EGFP mRNA: Optimizing Mammalian Cell Transfection Assay
2026-08-07
ARCA EGFP mRNA delivers precise, fluorescence-based quantification of transfection efficiency in mammalian cells, setting a new standard for reproducibility and workflow optimization. Its advanced ARCA capping and poly(A) tailing ensure robust expression and stability, making it indispensable for validating delivery systems and maximizing experimental success.
-
Quercetin Protects Cataract Lenses via Hippo Pathway Modulat
2026-08-06
This study elucidates how quercetin ameliorates cataract pathology by inactivating the Hippo signaling pathway, thereby preserving lens epithelial cell viability and reducing oxidative stress. The findings clarify a mechanistic link between Hippo pathway suppression and lens protection, highlighting quercetin’s promise for non-surgical cataract management.
-
Diethylmaleate in Redox Regulation: Protocols and Resistance
2026-08-06
Diethylmaleate enables precise modulation of cellular glutathione levels, driving breakthroughs in oxidative stress and resistance research. This guide delivers actionable workflows, protocol optimization tips, and advanced applications with direct relevance for redox biology and toxicology.
-
Bazedoxifene: Expanding SERM Horizons from Bone to Oncology
2026-08-05
This article delivers a thought-leadership exploration of Bazedoxifene’s dual role as a selective estrogen receptor modulator and an emerging inhibitor of the IL-6/GP130 signaling pathway. By blending mechanistic insight with strategic research guidance, it empowers translational researchers to leverage Bazedoxifene in both osteoporosis and oncology contexts. Key protocol parameters, competitive differentiation, and a forward-looking perspective on clinical translation are integrated throughout.
-
Trifluoperazine 2HCl in Metabolic-Neuroimmune Crosstalk Rese
2026-08-05
Explore the advanced utility of Trifluoperazine 2HCl as a dopamine D2 receptor inhibitor in dissecting metabolic-neuroimmune signaling. This article uniquely bridges dopaminergic pathway modulation and metabolic disease models, offering actionable insights for research assay design.
-
3-Methyladenine in Autophagy Research: Optimized Workflows a
2026-08-04
3-Methyladenine (3-MA) stands out for dissecting autophagy and PI3K signaling with precision, empowering organ protection and cancer research. This guide delivers actionable workflows, troubleshooting strategies, and practical integration of new mechanistic insights from estrogen-autophagy axis studies.
450 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page